Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 13/20 | 0.45 |
| ▸ | TACR1 | P25103 | 2/20 | 0.43 |
| ▸ | TACR3 | P29371 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6593919 | 0.94 | TACR2 (0.47) | TACR2TACR1TACR3 | |
| SCHEMBL6595750 | 0.90 | TACR2 (0.49) | TACR2TACR1 | |
| SCHEMBL6594022 | 0.89 | TACR2 (0.47) | TACR2TACR1TACR3 | |
| SCHEMBL6595375 | 0.89 | TACR2 (0.59) | TACR2TACR1 | |
| SCHEMBL6596390 | 0.88 | TACR2 (0.54) | TACR2TACR1 | |
| SCHEMBL6598035 | 0.88 | TACR2 (0.52) | TACR2TACR1 | |
| SCHEMBL6596443 | 0.87 | TACR2 (0.53) | TACR2TACR1 | |
| SCHEMBL6597471 | 0.87 | TACR2 (0.44) | TACR2TACR1TACR3 | |
| SCHEMBL6597632 | 0.86 | TACR2 (0.41) | TACR2 | |
| SCHEMBL6600168 | 0.86 | TACR2 (0.42) | TACR2TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888338-B1 | NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES | AVENTIS PHARMA INC (US) | 2004-11-17 | — | — | EP | disclosed |
| US-5932571-A | Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases | HOECHST MARION ROUSSEL, INC. (US) | 1999-08-03 | — | — | US | disclosed |